Meds & supplements › Cysteine
Medicine · Vitamin C
Cysteine hydrochloride injection, USP is indicated for use as an additive to amino acids solutions to meet nutritional requirements of neonates (preterm and term infants less than one month of age) requiring total parenteral nutrition.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
The following serious adverse reactions are discussed in greater detail in other sections of the prescribing information:
Adverse reactions with the use of cysteine hydrochloride injection were identified in clinical studies or postmarketing reports. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or to establish a causal relationship to drug exposure.
Cysteine hydrochloride injection, USP is contraindicated in:
sofidex [Internet]. Daloreum; c2026. Cysteine; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/cysteine
sofidex. (2026, August 3). Cysteine. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/cysteine
Cysteine. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/cysteine
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.